NCT02954848View on ClinicalTrials.gov

Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)

PHASE3CompletedINTERVENTIONAL

Enrollment

484

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

February 25, 2018

Study Completion Date

February 26, 2018

Conditions

Non-erosive Gastroesophageal Reflux Disease

Interventions

DRUG

Placebo

TAK-438 placebo-matching tablets

DRUG

TAK-438 10 mg

TAK-438 tablets

Trial Locations (30)

Unknown

Abiko

Yachiyo

Kasuya-gun

Kitakyushu

Wakasugi

Yukuhashi

Kōriyama

Asahikawa

Sapporo

Yokohama

Suzaki

Kitakatsuragi

Fujimi

Hiki-gun

Satte

Ōtawara

Arakawa-ku

Nakano-ku

Setagaya-ku

Shibuya-ku

Toshima-ku

Fukuoka

Hiroshima

Kochi

Kumamoto

Nagasaki

Osaka

Ōita

Shizuoka

Yamagata

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY